|
Volumn 116, Issue 4, 2002, Pages 781-786
|
High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma
|
Author keywords
Chronic lymphocytic leukaemia; High dose chlorambucil; Low grade non Hodgkin's lymphoma
|
Indexed keywords
CHLORAMBUCIL;
FLUDARABINE;
ADULT;
AGED;
ARTICLE;
AUTOIMMUNE HEMOLYTIC ANEMIA;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
MALE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CHLORAMBUCIL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LEUKEMIA, B-CELL, CHRONIC;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
RECURRENCE;
SURVIVAL RATE;
VIDARABINE;
|
EID: 0036122035
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0007-1048.2002.03362.x Document Type: Article |
Times cited : (19)
|
References (16)
|